Breaking News, Financial News

Financial Report: Sanofi

Exchange rates hurt results

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi 1Q Revenues: €7.8 billion (-3%) 1Q Earnings: €1.5 billion (-3%) Comments: Diabetes revenue was up 13% to €1.7 billion. Genzyme revenues were up 22% to €566 million, driven by Aubagio with sales of €78 million versus €20 million in 1Q13. Consumer Healthcare sales were up 19% to €885 million. Sanofi Pasteur vaccine sales were €628 million, down 4%, reflecting a phasing effect in Pentaxim deliveries in Emerging Markets, offset by strong sales for Imovax in Japan and Menactra in the previo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters